Article Text

other Versions

PDF
Extended report
Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis
  1. Oliver Frey1,
  2. Juliane Meisel1,
  3. Andreas Hutloff2,3,
  4. Kerstin Bonhagen1,
  5. Lisa Bruns1,
  6. Richard A Kroczek2,
  7. Lars Morawietz4,
  8. Thomas Kamradt1
  1. 1Institut für Immunologie, Universitätsklinikum Jena, Jena, Germany
  2. 2Robert-Koch-Institut, Berlin, Germany
  3. 3Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany
  4. 4Institut für Pathologie, Charité Universitätsmedizin Berlin, Berlin, Germany
  1. Correspondence to Thomas Kamradt, Institut für Immunologie, Universitätsklinikum Jena, Jena 07743, Germany; thomas.kamradt{at}mti.uni-jena.de

Abstract

Objectives Inducible costimulator (ICOS) and its ligand (ICOSL) regulate T and B cell responses. Glucose-6-phosphate isomerase (G6PI)-induced arthritis requires T and B lymphocytes. It was hypothesised that blocking ICOS/ICOSL interactions ameliorates G6PI-induced arthritis and reduces G6PI-specific B and T lymphocyte responses.

Methods DBA/1 mice were injected with a blocking, non-depleting anti-ICOSL monoclonal antibodies (mAbs) during the induction or effector phase of G6PI-induced arthritis. G6PI-specific antibody responses were measured by ELISA. G6PI-specific T helper (Th) cell responses were assayed by polychromatic flow cytometry.

Results Transient blockade of ICOS/ICOSL interactions profoundly reduced the severity of G6PI-induced arthritis. ELISA and proliferation assays showed no clear ex vivo correlates of protection. Polychromatic flow cytometry revealed two major findings: the absolute number of G6PI-specific Th cells was markedly diminished in secondary lymphatic organs from mice with blocked ICOS/ICOSL interactions. Within the pool of G6PI-specific Th cells the frequency of interleukin 17 (IL17), interferon γ or tumour necrosis factor α producers or polyfunctional Th cells (expressing two or more of these cytokines) was higher in treated than in control mice.

Conclusions ICOS costimulation is not mandatory for the differentiation of Th1 or Th17 cells. Instead, the lack of ICOS costimulation results in reduced survival of G6PI-specific Th cells irrespective of their functional differentiation. This study demonstrates that a thorough examination of the quantity and the quality of antigen-specific immune responses is useful to determine ex vivo correlates of efficacy for immunomodulating treatments.

Statistics from Altmetric.com

Footnotes

  • Competing interest None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent Obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.